Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 169 | 741 | 965 | 311 | 629 |
| Gross Profit | 169 | 741 | 965 | 311 | 629 |
| Operating Expenses | 21,983 | 29,102 | 19,532 | 19,554 | 21,192 |
| Operating Income | -21,814 | -28,361 | -18,567 | -19,243 | -20,563 |
| Other Income | 1,963 | -3,120 | 2,889 | 62,374 | -61,560 |
| Pre-tax Income | -19,851 | -31,481 | -15,678 | 43,131 | -82,123 |
| Income Tax | 30 | 56 | 185 | 43 | 27 |
| Net Income Continuous | -19,881 | -31,537 | -15,863 | 43,088 | -82,150 |
| Net Income | $-19,881 | $-31,537 | $-15,863 | $43,088 | $-82,150 |
| EPS Basic Total Ops | 4.23 | -3.04 | -1.53 | -2.11 | -13.10 |
| EPS Basic Continuous Ops | -3.00 | -3.04 | -1.53 | 5.12 | -13.10 |
| EPS Diluted Total Ops | 4.23 | -3.04 | -1.53 | -2.11 | -13.10 |
| EPS Diluted Continuous Ops | -2.82 | -3.04 | -1.53 | 4.95 | -13.10 |
| EPS Diluted Before Non-Recurring Items | -1.91 | -3.04 | -1.53 | -2.11 | -3.41 |
| EBITDA(a) | $-23,384 | $-28,373 | $-18,616 | $-18,870 | $-21,859 |